UBCPharmacyLiLab
@ubc_lilab
Followers
19
Following
17
Media
3
Statuses
13
Dr. Shyh-Dar Li's Lab at the Faculty of Pharmaceutical Sciences, University of British Columbia, focuses on drug delivery research.
Vancouver, BC, Canada
Joined August 2021
Dr. Li will speak at the W.E.S.T. Webinar hosted by @PrecisionNano on Wednesday, September 29, at 9 AM PT (11 AM CT). He will be presenting on Phospholipid-free Small Unilamellar Vesicles (PFSUVs) for Hepatocyte-targeted Drug Delivery. To register: https://t.co/vapETVdSqm
0
0
0
Our recent work on drug targeting to hepatocytes has been published in Molecular Pharmaceutics. Happy reading. https://t.co/nTjE0fjyDy
pubs.acs.org
Hemolytic toxicity caused by primaquine (PQ) is a high-risk condition that hampers the wide use of PQ to treat liver-stage malaria. This study demonstrated that phospholipid-free small unilamellar...
0
0
0
Congratulations to Nojoud AL Fayez for receiving “PhD Best Poster Award” at the 2021 Annual Meeting of the Canadian Society for Pharmaceutical Sciences (CSPS).
0
0
1
Congratulations to Anne Nguyen for receiving “CIHR Doctoral Award”, 2021
0
0
0
UBC will require COVID-19 testing for all students, faculty & staff, with exemptions provided for those who are fully vaccinated against COVID-19. A process for confidential self-disclosure of vaccination status, with functionality for verification, will be implemented next week.
0
50
223
COVID mRNA vaccines: While BNT and Moderna are on spotlight, key technologies were developed in labs in UBC, UPenn and NIH. Particularly, Canada is the driving force innovating the mRNA delivery technology, the key ingredient in those vaccines. https://t.co/1hiMXNICpz
nature.com
Nature Biotechnology - A preliminary network analysis highlights the complex intellectual property landscape behind mRNA-based COVID-19 vaccines.
0
0
0
Network analysis of intellectual property that paved the way for COVID-19 mRNA vaccines such as Pfizer/BioNTech and Moderna shows that two universities: University of Pennsylvania and the University of British Columbia played key roles. Nat Biotechnol 39, 546–548 (2021).
6
182
597
Our collaboration with Dr. Horacio Bach at Division of Infectious diseases, UBC has been published in Nanomaterials.
mdpi.com
Background: Pathogenic intracellular mycobacteria are challenging to treat because of the waxy and complex cell wall characterizing the genus. Niosomes are vesicles with biomimetic cell membrane...
0
0
0
Shyh-Dar Li et al. @ubcpharmacy on a Rapidly Dissolvable Oral #Pediatric Formulation for Mefloquine Using #Liposomes
https://t.co/4pHmQcrAmW
0
2
2
Check our recent publication that made to the cover story of Journal of Controlled Release: Altering the intra-liver distribution of phospholipid-free small unilamellar vesicles using temperature-dependent size-tunability https://t.co/yOqfa20Jqq
#livertargeting
#liverdiseases
0
0
0
The Li lab at UBC is recruiting postdocs for drug delivery research. Qualifications: PhD in chemistry, chemical engineering or related; First-author publications; Preferred research experiences: nanomedicines, protein engineering, gene therapy. Check webpage and email Dr. Li.
1
0
0
Check our recent publication: An Effective and Safe Enkephalin Analog for Antinociception. https://t.co/6fSrMXtL6D
#opioidcrisis
#chronicpain
mdpi.com
Opioids account for 69,000 overdose deaths per annum worldwide and cause serious side effects. Safer analgesics are urgently needed. The endogenous opioid peptide Leu-Enkephalin (Leu-ENK) is ineffe...
0
0
0